摘要
研究吸入糖皮质激素方式对支气管哮喘患者的治疗依从性。选取2019年在武警黑龙江总队医院诊治的支气管哮喘患者130例,根据数字表法将其划分为普通组与吸入组,每组65例。普通组患者采用常规治疗,服用孟鲁司特钠片,吸入组患者采用糖皮质激素吸入治疗,分析两组患者的治疗依从性。结果表明,吸入组患者十分依从占30例、一般依从占33例、不依从占2例,依从率达97.0%;普通组患者十分依从占28例、一般依从占30例、不依从占7例,依从率为89.3%。普通组患者的依从率显著低于吸入组(P<0.05);吸入组依从性高的占30例患者,依从性低的占35例患者,依从性高的患者病因平均分数为(5.29±0.13)分、病情严重者的平均分数(4.91±0.33)分、疾病管理平均分数(5.59±0.43)分。依从性低的患者病因平均分数为(3.62±0.21)分、病情严重者的平均分数(3.20±0.27)分、疾病管理平均分数(2.37±0.12)。依从性高的患者均优于依从性低的患者(P<0.05)。通过糖皮质激素吸入方式治疗支气管哮喘,可以增强患者治疗支气管哮喘的依从性,加深患者对病因、疾病管理与病情严重性等知识的印象,可缩短患者的临床治疗时间。
The paper analyzed the inhalation glucocorticoid on treatment compliance of patients with bronchial asthma.130 patients with bronchial asthma treated in Heilongjiang Armed Police Corps Hospital in 2019 were selected.They were divided into control group and inhalation group according to numeration table,with 65 patients in each group.Control group received Montelukast,and inhalation group received glucocorticoid.Treatment compliance of two groups was analyzed.In inhalation group,30 patients were very compliant,33 patients were generally compliant,2 patients were not compliant,and the compliance rate was 97.0%.In control group,28 patients were very compliant,30 patients were generally compliant,7 patients were not compliant,and the compliance rate was 89.3%.The compliance rate of control group was significantly lower than inhalation group(P<0.05).Pathogenesis average score of patients of high compliance was(5.29±0.13),that of patients under serious condition was(4.91±0.33),and that of disease management was(5.59±0.43).Pathogenesis average score of patients of low compliance was(3.62±0.21),that of patients under serious condition was(3.20±0.27),and that of disease management was(2.37±0.12).Patients of high compliance were superior to those of low compliance(P<0.05).Inhalation glucocorticoid on treatment of bronchial asthma can strengthen the compliance of patients with bronchial asthma,deepen the knowledge of pathogenesis,disease management and disease severity,and shorten the clinical treatment time of patients.
作者
侯英宇
李璐
王宇
Hou Yingyu;Li Lu;Wang Yu(Heilongjiang Armed Police Corps Hospital, Harbin 150079, China)
出处
《黑龙江科学》
2020年第16期56-57,共2页
Heilongjiang Science
关键词
支气管哮喘
吸入糖皮质激素
依从性
Bronchial asthma
Inhalation glucocorticoid
Compliance
